Financhill
Back

Nihon Chouzai Quote, Financials, Valuation and Earnings

Nihon Chouzai Price Quote

$16.03

Nihon Chouzai Key Stats

Sell
21
Nihon Chouzai (NHCZF) is a Sell

Day range:
$16.03 - $16.03
52-week range:
$16.03 - $16.03
Dividend yield:
1.05%
P/E ratio:
27.09
P/S ratio:
0.21
P/B ratio:
1.18%

Volume:
0
Avg. volume:
0
1-year change:
0%
Market cap:
$478.8M
Revenue:
$2.4B
EPS:
$0.4

How Much Does Nihon Chouzai Make?

Is Nihon Chouzai Growing As A Company?

  • What Is Nihon Chouzai's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.07%
  • What Is Nihon Chouzai's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Nihon Chouzai Stock Price Performance

  • Did Nihon Chouzai Stock Go Up Last Month?
    Nihon Chouzai share price went up by 0% last month
  • Did NHCZF's Share Price Rise Over The Last Year?
    NHCZF share price rose by 0% over the past 1 year

What Is Nihon Chouzai 52-Week High & Low?

Nihon Chouzai Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Nihon Chouzai?

  • How Much Debt Does Nihon Chouzai Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Nihon Chouzai Have?
    Cash and short term investments quarterly total is $172M
  • What Is Nihon Chouzai’s Book Value Per Share?
    Book value per share is 12.89

Is Nihon Chouzai Cash Flow Positive?

Data Unavailable

Nihon Chouzai Return On Invested Capital

  • Is Management Doing A Good Job?
    NHCZF return on invested capital is 1.59%
  • What Is Nihon Chouzai Return On Assets?
    ROA measures how assets are converting to revenues and is 0.91%
  • What Is NHCZF Return On Equity?
    ROE is a measure of profitability and is 4.44%

Nihon Chouzai Earnings Date & Stock Price

Nihon Chouzai Competitors

  • Who Are Nihon Chouzai's Competitors?
    Below is a list of companies who compete with Nihon Chouzai or are related in some way:
    • AnGes Inc (AMGXF)
    • Healios KK (HLOSF)
    • PeptiDream Inc (PPTDF)
    • Nxera Pharma Co Ltd (SOLTF)
    • Takeda Pharmaceutical Co Ltd (TAK)

Nihon Chouzai Dividend Yield

Nihon Chouzai Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -7.05% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many NHCZF shares are owned by institutional investors?
    2.8M NHCZF shares are owned by institutional investors
  • How many NHCZF shares are owned by insiders?
    0 NHCZF shares are owned by insiders